Luminex Gains Rights to ViroNovative IP for Use in Respiratory Viral Panel

Jul 14, 2008

NEW YORK (GenomeWeb News) – Luminex said today that it has signed an agreement with Dutch diagnostic developer ViroNovative that gives it worldwide rights to use the company’s human metapneumovirus intellectual property in its xTAG Respiratory Viral Panel.

Luminex said that its distributors and end-user customers around the world also have rights to use the ViroNovative IP under the terms of the agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Re-Think on Science Standards

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Graves Wins Top Australian Science Prize

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

Faster Efforts

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

This Week in Cell

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.

Main menu